Skip to main content
Clinical Trials/NCT06012526
NCT06012526
Completed
Not Applicable

Study of the Prevalence and Predictive Factors of Sleep Disordered Breathing in Patients With Interstitial Lung Diseases

Beni-Suef University1 site in 1 country69 target enrollmentNovember 25, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obstructive Sleep Apnea-hypopnea
Sponsor
Beni-Suef University
Enrollment
69
Locations
1
Primary Endpoint
Measurements of apnea hypopnea index
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This was a cross-sectional observational study to evaluate the prevalence and predictive factors of SDB in ILD and to analyze the relationship between polysomnography (PSG) findings, pulmonary function, disease severity, parenchymal involvement, and sleep questionnaires ESS and SBQ. This study included 69 patients who were diagnosed with diffuse parenchymal lung diseases by high-resolution computed tomography (HRCT) chest. All patients were subjected to clinical examination, HRCT, spirometry, full-night polysomnography, and echocardiography.

Registry
clinicaltrials.gov
Start Date
November 25, 2020
End Date
July 24, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mona Mahmoud Srour Soliman

Assistant lecturer

Beni-Suef University

Eligibility Criteria

Inclusion Criteria

  • Both sexes of clinically stable ILD patients older than 18 who met the ATS/ERS criteria for an ILD diagnosis were included in the study.

Exclusion Criteria

  • Patients who have any anatomic upper airway obstructions such as significant nasal septal deviation, nasal polyps, conchae hypertrophy or tonsillar hypertrophy.
  • Patients with neurological diseases or severe psychiatric disorders.
  • Patients who have history of administration of any drug that has a major effect on sleep e.g. benzodiazepine, narcotic drugs ....etc.
  • Patients with any chronic pulmonary disease except ILD.
  • Total sleep time less than 4 hours on PSG.

Outcomes

Primary Outcomes

Measurements of apnea hypopnea index

Time Frame: 1and half years

Polysomnography can measure apnea hypopnea index of all patients to detect sleep disordered breathing

Study Sites (1)

Loading locations...

Similar Trials